A cancer stem cell marker DclK1, which is also reported to be expressed in PanIN and facilitate tumor progression in KRAS‐mutated mice and human pancreatic cancer, was upregulated by cerulein 28. Here, DCLK1 is linked to pancreatic neoplasm.